Jpmorgan Chase & CO Beyond Spring Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding BYSI
# of Institutions
21Shares Held
5.61MCall Options Held
288KPut Options Held
0-
Decheng Capital LLC Menlo Park, CA4.53MShares$7.43 Million2.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA524KShares$858,8660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA256KShares$420,1870.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$353,1820.0% of portfolio
-
Tanaka Capital Management Inc New York, NY26.3KShares$43,1250.09% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $63.8M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...